Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SIX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.
Discovering and developing innovative therapeutics for CNS disorders
Investors
Reports, Presentations & Fact sheet - latest
| Title: | |
|---|---|
MDS 14th International Congress 6 posters (safinamide)17/06/2010 |  |
Media and analyst conference - 2009 results MP3 file03/03/2010 | |
Media and analyst conference - 2009 results presentation03/03/2010 | |
Progetto di Bilancio d'Esercizio03/03/2010 | |
Annual Report 200903/03/2010 | |
EFIC 2009 poster (ralfinamide)11/09/2009 | |
Half - Year Report 200910/09/2009 | |
Investor and analyst call: safinamide phase III results presentation - MP3 file10/06/2009 | |
Investor and analyst call: safinamide phase III results presentation10/06/2009 | |
MDS 13th International Congress poster (safinamide)10/06/2009 | |